Xinghai Li

1.8k citations

36 papers · 1.5k indexed · h-index 23

Co-authors: Ashutosh Chilkoti Wenge Liu Jayanta Bhattacharyya Jonathan R. McDaniel Isaac Weitzhandler Yizhi Qi Kelli M. Luginbuhl Jeffrey L. Schaal
Topics: Nanoparticle-Based Drug Delivery (12 papers)Connective tissue disorders research (7 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)
Cited by: Biomaterials Surfaces, Coatings and Films Pharmaceutical Science
Journals: Proceedings of the National Academy of Sciences Angewandte Chemie International Edition Nature Communications
Partner nations: United States India Japan

In The Last Decade

Xinghai Li

36 papers receiving 1.5k citations

Peers

Countries citing papers authored by Xinghai Li

Since Specialization

Citations

This map shows the geographic impact of Xinghai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghai Li more than expected).

Fields of papers citing papers by Xinghai Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghai Li. The network helps show where Xinghai Li may publish in the future.

Co-authorship network of co-authors of Xinghai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghai Li. A scholar is included among the top collaborators of Xinghai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghai Li. Xinghai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Controlling Release Kinetics of an Adjuvant from a Depot Improves the Efficacy of Local Immunotherapy in Metastatic Cancer 2025 ·Advanced Science ·Joshua J. Milligan,(unknown),Amit Chakrabarty,(unknown),(unknown),Jonathan C. Su,Anastasia K. Varanko,(unknown),(unknown),Cassio M. Fontes,(unknown),(unknown),Yun‐Xing Wang,Lixin Fan,Xinghai Li,Smita K. Nair,Ashutosh Chilkoti	2
2	Preclinical Development of a Genetically Engineered Albumin‐Binding Nanoparticle of Paclitaxel 2024 ·SHILAP Revista de lepidopterología ·Soumen Saha,Samagya Banskota,Parisa Yousefpour,Jeffrey L. Schaal,(unknown),Jianqiao Liu,Michael Dzuricky,(unknown),Stefan Roberts,Xinghai Li,Ashutosh Chilkoti	3
3	An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug 2023 ·Biomaterials ·İmran Özer,(unknown),(unknown),Xinghai Li,(unknown),(unknown),Jeffrey I. Everitt,Ivan Spasojević,Stephen L. Craig,Joel H. Collier,Jonathan E. Campbell,David A. D’Alessio,Ashutosh Chilkoti	17
4	Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours 2022 ·Nature Biomedical Engineering ·Jeffrey L. Schaal,Jayanta Bhattacharyya,(unknown),Kyle C. Strickland,(unknown),Soumen Saha,Joshua J. Milligan,Samagya Banskota,Xinghai Li,Wenge Liu,David G. Kirsch,Michael R. Zalutsky,Ashutosh Chilkoti	27
5	Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot 2022 ·Journal of Controlled Release ·(unknown),Joshua J. Milligan,Eric M. Mastria,Sarah Kim,(unknown),(unknown),(unknown),Xinghai Li,Smita K. Nair,Ashutosh Chilkoti	27
6	Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models 2019 ·Science Advances ·Mandana T. Manzari,Grace R. Anderson,Kevin Lin,Ryan S. Soderquist,Merve Çakır,(unknown),(unknown),(unknown),M. Fèvre,Xinghai Li,Joseph J. Bellucci,Suzanne E. Wardell,Simone A. Costa,Kris C. Wood,Ashutosh Chilkoti	13
7	Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery 2018 ·Biomaterials ·Samagya Banskota,Parisa Yousefpour,(unknown),Xinghai Li,Ashutosh Chilkoti	76
8	Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy 2018 ·Nano Letters ·Parisa Yousefpour,Jonathan R. McDaniel,(unknown),Lucie Ahn,Xinghai Li,(unknown),Isaac Weitzhandler,Steven E. Suter,Ashutosh Chilkoti	41
9	Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity 2017 ·Journal of Controlled Release ·Eric M. Mastria,(unknown),Matthew J. Kan,Xinghai Li,Jeffrey L. Schaal,Steven Fiering,Michael D. Gunn,Mark W. Dewhirst,Smita K. Nair,Ashutosh Chilkoti	54
10	One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer 2017 ·Nature Biomedical Engineering ·Kelli M. Luginbuhl,Jeffrey L. Schaal,(unknown),Eric M. Mastria,Xinghai Li,Samagya Banskota,Susan Arnold,Mark N. Feinglos,David A. D’Alessio,Ashutosh Chilkoti	102
11	Encapsulating a Hydrophilic Chemotherapeutic into Rod‐Like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves Its Efficacy 2017 ·Advanced Functional Materials ·Jayanta Bhattacharyya,Isaac Weitzhandler,(unknown),Jonathan R. McDaniel,Xinghai Li,Lei Tang,Jinyao Liu,Mark W. Dewhirst,Ashutosh Chilkoti	31
12	A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly(ethylene glycol) antigenicity 2016 ·Nature Biomedical Engineering ·Yizhi Qi,Antonina Simakova,Nancy J. Ganson,Xinghai Li,Kelli M. Luginbuhl,İmran Özer,Wenge Liu,Michael S. Hershfield,Krzysztof Matyjaszewski,Ashutosh Chilkoti	109
13	Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy 2016 ·Journal of Controlled Release ·Jeffrey L. Schaal,Xinghai Li,Eric M. Mastria,Jayanta Bhattacharyya,Michael R. Zalutsky,Ashutosh Chilkoti,Wenge Liu	58
14	A Modular Method for the High‐Yield Synthesis of Site‐Specific Protein–Polymer Therapeutics 2016 ·Angewandte Chemie International Edition ·Yan Pang,Jinyao Liu,Yizhi Qi,Xinghai Li,Ashutosh Chilkoti	35
15	Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor 2015 ·Biomaterials ·(unknown),Jeffrey L. Schaal,Xinghai Li,Jayanta Bhattacharyya,Daisuke Asai,Michael R. Zalutsky,Ashutosh Chilkoti,Wenge Liu	35
16	A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models 2015 ·Nature Communications ·Jayanta Bhattacharyya,Joseph J. Bellucci,Isaac Weitzhandler,Jonathan R. McDaniel,Ivan Spasojević,Xinghai Li,Chao‐Chieh Lin,Jen‐Tsan Chi,Ashutosh Chilkoti	186
17	Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma 2015 ·Journal of Controlled Release ·Eric M. Mastria,Mingnan Chen,Jonathan R. McDaniel,Xinghai Li,Jinho Hyun,Mark W. Dewhirst,Ashutosh Chilkoti	48
18	Site‐Specific Zwitterionic Polymer Conjugates of a Protein Have Long Plasma Circulation 2015 ·ChemBioChem ·Somnath Bhattacharjee,Wenge Liu,Weihan Wang,Isaac Weitzhandler,Xinghai Li,Yizhi Qi,Jinyao Liu,Yan Pang,Donald F. Hunt,Ashutosh Chilkoti	33
19	Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model 2015 ·Cancer Research ·Jeffrey L. Schaal,Wenge Liu,Ashutosh Chilkoti,Xinghai Li,Eric M. Mastria,Michael R. Zalutsky	2
20	Brachytherapy Using Injectable Seeds That Are Self-Assembled from Genetically Encoded Polypeptides In Situ 2012 ·Cancer Research ·Wenge Liu,Jonathan R. McDaniel,Xinghai Li,Daisuke Asai,Felipe García Quiroz,Jeffrey L. Schaal,Ji Sun Park,Michael R. Zalutsky,Ashutosh Chilkoti	41

About Xinghai Li

Xinghai Li is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Connective tissue disorders research (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Biomaterials (775 citations), Surfaces, Coatings and Films (116 citations) and Pharmaceutical Science (81 citations). Xinghai Li has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Ashutosh Chilkoti, Wenge Liu, Jayanta Bhattacharyya, Jonathan R. McDaniel, Isaac Weitzhandler, Yizhi Qi, Kelli M. Luginbuhl, Jeffrey L. Schaal, Eric M. Mastria and Jinyao Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact